The European Commission has published Regulation (EU) 2026/909 amending Regulation (EC) No 1223/2009 of the European Parliament and of the Council as regards cosmetic ingredients in its Annexes II, III, V and VI. Following the publication of the draft Regulation in...
Legal Cosmetic Area
Trimethyl Pentanyl Diisobutyrate – Consultations on harmonised classification and labelling (CLH)
Norway has submitted a classification and labeling consultation for the ingredient 1-isopropyl-2,2-dimethyltrimethylene diisobutyrate (Trimethyl pentanyl diisobutyrate).
Silver Chloride – Consultations on harmonised classification and labelling (CLH)
The public consultation period has begun on the proposal for harmonised classification and labelling (CLH) for the ingredient Silver Chloride, used in cosmetic products as a preservative. ECHA has announced Sweden’s intention to classify the ingredient Silver Chloride...
Cannabidiol (CBD) – Final Scientific Advice
The SCCS has published its Final Scientific Advice (SCCS/1685/25) on the use of the ingredient Cannabidiol (CBD) in cosmetic products. Following the mandate of the European Commission and the preliminary opinion, the safety of Cannabidiol (CBD) (CAS No. 13956-29-1, EC...
Silver – Final Scientific Advice
The SCCS has published its Final Scientific Advice (SCCS/1687/25) on the use of the ingredient Silver in cosmetic products. Following the mandate of the European Commission and the preliminary scientific advice, the safety of Silver (CAS No. 7440-22-4, EC No....
BHA – Final Scientific Advice
The SCCS has published its Final Scientific Advice (SCCS/1682/25) on the use of the ingredient Butylated Hydroxyanisole (BHA) in cosmetic products. Following the mandate of the European Commission, and the preliminary scientific advice, the safety of Butylated...
Ethylhexyl Methoxycinnamate (EHMC) – Corrigendum
Following the Final Opinion of June 2025, a corrigendum (SCCS/1671/24) has been adopted to clarify the use of the ingredient Ethylhexyl Methoxycinnamate (EHMC) as a UV stabiliser. This corrigendum aims to improve the clarity of the original text and to avoid possible...
Heliotropin – Preliminary Opinion
The SCCS has published its Preliminary Opinion (SCCS/1688/26) on the use of the ingredient Heliotropin in cosmetic products. Following a mandate from the European Commission, the preliminary opinion on the safety of Heliotropin (CAS No. 120-57-0, EC No. 204-409-7) has...
Benzophenone-2 and Benzophenone-5 – Corrigendum
Following the Final Scientific Advice of June 2025, a corrigendum has been adopted (SCCS/1679/25) to align the tables for Benzophenone-5 with those for Benzophenone-4. It now also includes the safety assessment of all leave-on and rinse-off products (total dermal...
Omnibus VI – The European Parliament publishes its position
Following the position adopted by the Council of the EU in November 2025, which set out its approach to the Omnibus VI package with the aim of simplifying the regulatory framework, the proposal has taken a key step forward after Members of the European Parliament...
13th SCCS Plenary Meeting
On 26 March 2026, the SCCS held its 13th Plenary Meeting, during which various documents related to cosmetic ingredients were discussed and adopted. List of points discussed: Working Group (WG) on Cosmetic Ingredients: Final opinions: Cannabidiol – CBD Butylated...
Working Group Meeting on Cosmetic Ingredients
On 25 March 2026, in Luxembourg, the SCCS held the Working Group Meeting on Cosmetic Ingredients to advance the evaluation of scientific opinions and review the status of ongoing dossiers. List of points discussed: Draft mandate: DG GROW informed about two calls for...



